600535 fundamentals
An in-depth look to TASLY PHARMACEUTICA GROUP operating, investing, and financing activities
600535 free cash flow for Q1 24 is -428.07 M CNY. For 2023, 600535 free cash flow was 1.94 B CNY and operating cash flow was 2.61 B CNY.
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: CNY
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
TTM